Cargando…

Anti proliferative activity of ELACYT™ (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

This study evaluated combination drug partners for CP-4055, the C18:1(Δ9,trans) unsaturated fatty acid ester of cytarabine in HL-60 and U937 cells. Growth inhibition was assessed by ATP assay and drug interaction by the combination index and three dimensional methods. Synergy was observed in HL-60 c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adams, David J., Sandvold, Marit L., Myhren, Finn, Jacobsen, Tove F., Giles, Frank, Rizzieri, David A.
Formato:	Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562023/ https://www.ncbi.nlm.nih.gov/pubmed/18398748 http://dx.doi.org/10.1080/10428190801935752

Ejemplares similares

Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study
por: Aktas, Gokmen, et al.
Publicado: (2016)

Effect of Salmonella enterica serovar Typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression
por: Coutermarsh-Ott, Sheryl L., et al.
Publicado: (2017)

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
por: Bergman, Andries M., et al.
Publicado: (2010)

VNP: Interactive Visual Network Pharmacology of Diseases, Targets, and Drugs
por: Hu, Q-N, et al.
Publicado: (2014)

Chloroquine enhanced the anticancer capacity of VNP20009 by inhibiting autophagy
por: Zhang, Xiaoxin, et al.
Publicado: (2016)

Corrigendum: Chloroquine enhanced the anticancer capacity of VNP20009 by inhibiting autophagy
por: Zhang, Xiaoxin, et al.
Publicado: (2016)

Confocal microscopy of idarubicin localisation.
por: Manfait, M., et al.
Publicado: (1997)

Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance)
por: Chhibber, Aparna, et al.
Publicado: (2014)

Confocal microscopy of idarubicin localisation - reply
por: Duffy, P, et al.
Publicado: (1997)

Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer
por: Forster, Richard E. J., et al.
Publicado: (2010)

The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009
por: Zhang, Xiaoxin, et al.
Publicado: (2016)

Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy.
por: Sliutz, G., et al.
Publicado: (1996)

Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126
por: Adema, Auke D., et al.
Publicado: (2011)

Intra-Arterial Delivery of Idarubicin in Two Patients with Glioblastoma
por: Chehimi, Mohamad, et al.
Publicado: (2016)

Commentary: Periocular topotecan for retinoblastoma
por: Sharma, Minal, et al.
Publicado: (2018)

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2023)

Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
por: Wilbur, H. Catherine, et al.
Publicado: (2023)

The induction of apoptosis by daunorubicin and idarubicin in human trisomic and diabetic fibroblasts
por: Dragojew, Sylwia, et al.
Publicado: (2008)

Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
por: Taşkın, Abdullah, et al.
Publicado: (2019)

Idarubicin–Gold Complex: From Crystal Growth to Gold Nanoparticles
por: Barbey, Carole, et al.
Publicado: (2021)

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma
por: Ulrich-Pur, H, et al.
Publicado: (2003)

Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
por: Ioka, T, et al.
Publicado: (2017)

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
por: Blanchette, P., et al.
Publicado: (2012)

Periocular topotecan for vitreous seeds in retinoblastoma
por: Sthapit, Purnima R, et al.
Publicado: (2018)

Culture of attenuated Salmonella Typhimurium VNP20009 in animal-product-free media does not alter schwannoma growth control
por: Ahmed, Sherif G., et al.
Publicado: (2023)

Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile
por: Giovannetti, E, et al.
Publicado: (2005)

Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3
por: Komiyama, Tomoyoshi, et al.
Publicado: (2016)

Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus
por: She, Pengfei, et al.
Publicado: (2020)

Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
por: Roth, Gaël Stéphane, et al.
Publicado: (2020)

Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia
por: Sherif, Hemat Afifi, et al.
Publicado: (2021)

Correction to “Idarubicin–Gold Complex: From Crystal Growth to Gold Nanoparticles”
por: Barbey, Carole, et al.
Publicado: (2022)

Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice
por: Zhang, Yong, et al.
Publicado: (2015)

Prevention of allergy by virus‐like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model
por: Kratzer, Bernhard, et al.
Publicado: (2018)

The Vibriolysin-Like Protease VnpA and the Collagenase ColA Are Required for Full Virulence of the Bivalve Mollusks Pathogen Vibrio neptunius
por: Galvis, Fabián, et al.
Publicado: (2021)

Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma
por: Wu, Leyang, et al.
Publicado: (2022)

Optimization of liposomal topotecan for use in treating neuroblastoma
por: Chernov, Lina, et al.
Publicado: (2017)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
por: Guiu, Boris, et al.
Publicado: (2019)

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial
por: Holtan, Shernan G., et al.
Publicado: (2012)

CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan
por: Blume, Joshua, et al.
Publicado: (2023)

Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101
por: Barginear, Myra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e232d4kee2kd5l4qcub3i8oenm